Home About Us Services Markets Resarch Online Trading Back Office Contact Us Download
Cipla Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln
 BSE Code
 500087
ISIN Demat
INE059A01026
Book Value
320.5640364
Mar.Cap(Rs.Cr)
113,132.18
P/E
34.40
Face Value
2
Go
Your are on :   Markets   |  Company Profile   |  Profit And Loss
ParticularsMar 2023
(Rs.Cr)
Mar 2022
(Rs.Cr)
Mar 2021
(Rs.Cr)
Mar 2020
(Rs.Cr)
Mar 2019
(Rs.Cr)
Mar 2018
(Rs.Cr)
INCOME :      
Sales Turnover 15790.6015380.8211302.7112659.1512374.0111444.81
Excise Duty0.000.000.000.000.0054.91
Net Sales15790.6015380.8211302.7112659.1512374.0111389.90
Other Income 500.73742.05653.91892.85577.52334.88
Stock Adjustments -205.26541.93-6.4143.08-136.70212.05
Total Income16086.0716664.8011950.2113595.0812814.8311936.83
EXPENDITURE :      
Raw Materials 5496.166467.544097.204362.294371.464367.54
Power & Fuel Cost257.07247.58234.58253.95264.93239.01
Employee Cost 2380.682122.021703.581911.081839.841785.94
Other Manufacturing Expenses 988.99994.55906.09921.04861.96851.23
Selling & Administrative Expenses 2334.972107.171578.592093.922030.011786.12
Miscellaneous Expenses 520.79272.66-291.15452.66367.11454.08
Less : Pre-operative Expenses Capitalised 0.000.000.000.000.000.00
Total Expenditure11978.6612211.528228.899994.949735.319483.92
Operating Profit4107.414453.283721.323600.143079.522452.91
Interest 27.0226.9345.0736.0516.9711.90
Gross Profit4080.394426.353676.253564.093062.552441.01
Depreciation595.91546.62468.62599.78569.72529.61
Profit Before Tax3484.483879.733207.632964.312492.831911.40
Tax1011.10949.49756.27545.96576.43431.33
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-40.09-27.69-16.92100.1827.9911.55
Reported Net Profit2513.472957.932468.282318.171888.411468.52
Extraordinary Items -40.2848.8839.0991.4079.1511.89
Adjusted Net Profit2553.752909.052429.192226.771809.261456.63
Adjustment below Net Profit -10.5218.4813.71-49.53-32.59-26.56
P & L Balance brought forward17534.7714961.7112479.7210828.569214.317933.29
Statutory Appropriations0.000.000.000.000.000.00
Appropriations 403.50403.350.00617.48241.57160.94
P & L Balance carried down19634.2217534.7714961.7112479.7210828.569214.31
Dividend0.000.000.00322.490.00241.54
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %425.00250.00250.00200.00150.00150.00
Dividend Per Share(Rs)8.505.005.004.003.003.00
Earnings Per Share-Unit Curr31.1436.6630.6128.7523.4418.24
Earnings Per Share(Adj)-Unit Curr31.1436.6630.6128.7523.4418.24
Book Value-Unit Curr305.25279.05247.10215.85195.88175.30
Book Value(Adj)-Unit Curr305.25279.05247.10215.85195.88175.30
Product Disclaimer Mandatory Information Privacy Policy Careers Risk disclosures Feedback Scores Member Bank Details
"Investor Grievance" Mail your Grievance to info@lalkar.in Important Links:   SEBI  |  NSE  |  BSE  |  MCX-SX  |  MCX   |   NCDEX  |  NSDL  |  CDSL  |  FMC   |   CDSL E-Voting  |  SMART ODR
SEBI REGISTRATION NOS - BSE CASH: INZ000269434  |  BSE FNO: INZ000269434  |  NSE CASH: INZ000269434  |  NSE FNO: INZ000269434  |  NSE CD: INZ000269434  |  MSEI CASH: INZ000269434   |   MSEI FNO: INZ000269434   |   MSEI CD: INZ000269434
AMFI NO : ARN- 19226  |  LALKAR COMMODITIES PVT. LTD.: MCX: 10685 FMC: MCX/TCM/CORP/0655 | NSEL: 11300 | NCDEX: 1130 FMC No : NCDEX/TCM/CORP/1106
2010 © Lalkar Group. All rights reserved Designed, developed & powered by CMOTS Infotech(ISO 9001:2015 certified)